Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacific Biosciences of California Inc (NASDAQ:PACB)

4.29
Delayed Data
As of Oct 23
 -0.11 / -2.50%
Today’s Change
3.08
Today|||52-Week Range
9.07
+12.89%
Year-to-Date

Today’s Trading

Previous close4.40
Today’s open4.39
Day’s range4.29 - 4.47
Volume578,041
Average volume (3 months)992,401
Market cap$508.6M
Dividend yield--
Data as of 10/23/2017

Growth & Valuation

Earnings growth (last year)-97.62%
Earnings growth (this year)-7.63%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)-2.23%
P/E ratioNM
Price/Sales3.73
Price/Book4.82

Competitors

 Today’s
change
Today’s
% change
HBIOHarvard Bioscience I...-0.10-2.74%
BIOBBio Rad Laboratories...+4.70+2.15%
ROKARoka Bioscience Inc-0.27-17.65%
AXDXAccelerate Diagnosti...-0.35-1.76%
Data as of 10/23/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$90.7M
Annual profit (last year)-$74.4M
Net profit margin-81.99%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael W. Hunkapiller
CFO, Principal Accounting Officer &
Executive VP
Susan K. Barnes
Corporate headquarters
Menlo Park, California

Forecasts